BridgeBio Pharma, Inc. (BIT:1BBIO)
Italy flag Italy · Delayed Price · Currency is EUR
36.20
0.00 (0.00%)
At close: Jul 24, 2025, 5:30 PM CET

BridgeBio Pharma Revenue

BridgeBio Pharma had revenue of $116.63M USD in the quarter ending March 31, 2025, a decrease of -44.76%. This brings the company's revenue in the last twelve months to $127.42M, down -41.71% year-over-year. In the year 2024, BridgeBio Pharma had annual revenue of $221.90M with 2,285.27% growth.

Revenue (ttm)
$127.42M
Revenue Growth
-41.71%
P/S Ratio
62.48
Revenue / Employee
$174.54K
Employees
730
Market Cap
7.37B EUR

Revenue Chart

Created with Highcharts 11.4.8BridgeBio Pharma Revenue - Annual8.25M8.25M69.72M69.72M77.65M77.65M9.30M9.30M221.9M221.9M20202021202220232024-50M100M150M200M
* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024221.90M212.60M2,285.27%
Dec 31, 20239.30M-68.35M-88.02%
Dec 31, 202277.65M7.93M11.38%
Dec 31, 202169.72M61.47M745.14%
Dec 31, 20208.25M-32.31M-79.66%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UniCredit24.79B
Intesa Sanpaolo25.43B
Enel SpA78.35B
Ferrari6.88B
Assicurazioni Generali55.30B
Eni S.p.A.90.96B
Leonardo S.p.a.18.26B
Stellantis156.88B
Revenue Rankings